HOPA Virtual Practice Management Series

image introducing HOPA's Virtual Practice Management Series Spacer Image

New Starting with Q1 2026: FREE Virtual Practice Management Sessions

Designed to Keep Practice Managers, Managing Their Practice

What if you could get practice management learning without leaving your practice for the day? Now you can! HOPA’s Virtual Practice Management (PM) Series brings educational content and continuing education (CE) credits to you four times a year - and now it's FREE for HOPA members!

Our Virtual Practice Management Series:

  • Provides single-topic, 60-90-minute webinars
  • Makes live CE credits available more frequently
  • Creates a consistent flow of timely practice management learning
  • Removes travel, time off, and cost barriers of in-person learning
Spacer Image An orange button that says click here to register Spacer Image

2026 Q1 Virtual Practice Management

"Bridging the Gap: Managing Transitions of Care for Complex Therapies"

  • Live on Tuesday, March 3, at 2-3:25 p.m. CT
  • Cost: Free for HOPA members, $34 for non-members

Session description

As the lines between inpatient and outpatient treatments, academic and community settings, and home therapy continue to blur, the role of the pharmacist becomes increasingly vital in coordinating care. This moderated panel discussion will focus on the coordination of care for complex cancer treatments, including bispecific, cellular, and gene therapies. Featuring an inpatient pharmacist, an academic ambulatory pharmacist, and a community infusion center pharmacist, the panel will explore the unique challenges and opportunities at each site.

Additionally, the discussion will highlight how emerging technologies, such as remote monitoring and home infusion capabilities, are shaping the future of oncology care. Through enhanced collaboration and innovative solutions, pharmacists can help reduce cancer disparities, improve patient experiences, and optimize treatment outcomes.

Learning objectives

  1. Identify barriers and solutions to integrating complex therapies into clinical practice
  2. Explain opportunities for the coordination of care between academic and community practices
  3. Outline the opportunities for community practice to integrate complex cancer therapies into their practice
  4. Summarize the role of the pharmacist in the coordination of care of complex therapies including establishing protocols for safe administration
  5. Evaluate case-based examples of transitions of care models and their impact on patient safety, adherence, and clinical outcomes

There will be 1.25 ACPE CE credits available for this session.

Meet our presenters

Amanda Pawlenty, PharmD, BCOP, RPh

Amanda Pawlenty headshot

Amanda Pawlenty is the Senior Clinical Manager of the inpatient hematology, oncology, BMT pharmacy practice at the Mayo Clinic. She went to pharmacy school at Creighton University, completed her PGY1 Residency at Froedtert Hospital in Milwaukee, and her PGY2 Oncology Residency at Wake Forest in North Carolina. After her PGY2, she came to the Mayo Clinic, where she's been practicing for more than 10 years, most recently focusing on the growth of the CAR-T, TIL, and bispecific inpatient practices in her role as Senior Clinical Manager.

Grant Perschke, PharmD

Grant Perschke headshot

Grant Perschke is an ambulatory oncology pharmacist at a community cancer center within the Mayo Clinic Health System. Grant has expanded pharmacy services as the first ambulatory oncology pharmacist at Mayo Clinic Health System - La Crosse. He has developed and implemented a pharmacist-driven monitoring program for patients receiving bispecific antibodies and oral antineoplastic medications. Grant has also established a drug repository at his facility to increase access to medications for financially underserved patients.

Tyler Sandahl, PharmD, BCOP, RPh

Tyler Sandahl headshot

Tyler Sandahl is a board-certified oncology pharmacist who works as a clinical specialist and instructor of pharmacy in the multiple myeloma clinic at the Mayo Clinic in Rochester, MN. She trained at the University of Iowa College of Pharmacy, Iowa City VA Healthcare System, and University of Utah Huntsman Cancer Hospital. Her areas of interest include plasma cell disorders, cellular therapies, and improving access to care for patients.

Scott Soefje, PharmD, BCOP, FCCP, FHOPA

Scott Soefje headshot

Scott Soefje is the Director of Pharmacy, Cancer Care and an Associate Professor of Pharmacy at the Mayo Clinic in Rochester, MN, where he oversees the cancer care service line for the pharmacy. He earned pharmacy degrees from the University of Texas at Austin and an MBA from the George Washington University. He completed a Specialty Residency in Oncology Pharmacy at the San Antonio VA and a Clinical Pharmacology Fellowship at MD Anderson Cancer Center. He is Board Certified in Oncology Pharmacy, a Past President of HOPA, and recognized as a Fellow of ACCP and HOPA. He has a breadth of cancer care pharmacy experience from academia to clinical practice to industry to cancer care administration.

Spacer Image

Future Virtual Practice Management sessions

Q2-4 2026

  • Topics and times to be determined

Are you well-versed in practice management but new to presenting live education? Virtual PM webinars are a great place to get started as a subject matter expert! Stay tuned for open calls for the rest of the 2026 Virtual Practice Management schedule.

Questions? Contact the HOPA Education team at education@hoparx.org.


Founding Sponsor

We would like to acknowledge Genentech as the Founding Sponsor of our 2026 Virtual Practice Management Series. Thank you for your valued support!

Genentech centered